Marge Lammert, Victor-Felix Mautner, and Lan Kluwe
Superficial Neurofibroma: A Lesion with Unique MRI Characteristics in Patients with Neurofibromatosis Type 1
Ruth Lim, Diego Jaramillo, Tina Young Poussaint, Yuchiao Chang and Bruce Korf.
Ferner RE, Hughes RA, Hall SM, Upadhyaya M, Johnson MR.
Rosalie E Ferner, Department of Neurology, Guy’s and St Thomas’ Hospitals, London, UK
D. Gareth R. Evans
Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2: tumor control and hearing preservation
Phi JH, Kim DG, Chung HT, Lee J, Paek SH, Jung HW
Lau YKI, Murray LB, Houshmandi SS, Xu Y, Gutmann DH, Yu Q
Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates
Mathieu D et al.
Scott R. Plotkin, M.D., Ph.D., Caroline C. O’Donnell, B.A., R.N., William T. Curry Jr., M.D., Catherine M. Bove, M.Ed., A.P.N.G., Mia MacCollin, M.D., and Fabio P. Nunes, M.D.
Participating in Research
People with NF play an important role in the development of new treatments of neurofibromatosis by participating in clinical trials. If you are interested in participating in a trial, please visit our page on the subject.